Table 3.
Adverse events of rituximab during follow-up.
| Events | Patients (n = 48) |
|---|---|
| Hypertension | 0 |
| Gastrointestinal pain | 0 |
| Nausea or vomiting | 1 |
| Carbuncle | 1 |
| Abnormal ALT/AST | 4 |
| Urinary tract infection | 2 |
| Pneumonia | 2 |
| Rash or pruritis | 5 |
| Influenza-like symptoms | 1 |
| Headache or dizziness | 0 |
| Angioedema | 0 |
| Leucopenia or neutropenia | 0 |
ALT: alanine aminotransferase; AST: aspartate aminotransferase